未出现严重充血性心力衰竭的患者。
确诊为心力衰竭的患者经我院心内科正规药物治疗半年后再进行追踪复查。
To track review the Patients with diagnosed heart failure by the Department of Cardiology into the hospital after six months of regular drug treatment.
它可以发生在健康人群，更常发生在有器质性心脏病和充血性心力衰竭的患者人群。
It can happen in healthy people, more frequent in organic heart disease, and congestive heart failure patients.
排除患有不稳定心绞痛、近期发生心肌梗塞或急性心力衰竭的患者以及左心室射血分数<40%的患者。
Patients with unstable angina, a recent history of MI or acute heart failure, or an LVEF <40% were excluded.
因为新的和恶化的充血性心力衰竭的案例已经在certolizumab治疗中有报导，所以心力衰竭的患者应该小心治疗、细心监视。
Because cases of new and worsening congestive heart failure have been reported with certolizumab therapy, patients with heart failure should be treated with caution and monitored carefully.
心碎综合症患者的症状类似于心力衰竭和心脏病。
People with the syndrome experience heart failure or heart attack-like symptoms.
虽然治疗方式从药物到心脏移植有很多，但高达40%的患者在确诊一年内去世，心力衰竭的生存率比许多癌症都低。
Treatments range from drugs to transplants but with up to 40 per cent of those affected dying within a year of diagnosis, heart failure has worse survival rate than many cancers.
血清ptx3水平为心力衰竭患者危险分层提供了重要的预后信息。
The plasma PTX3 level provides important prognostic information for the risk stratification of patients with heart failure.
《国际循环》：再生治疗为心血管疾病包括心力衰竭患者提供了一个有前景的治疗方法。
International Circulation: Regenerative medicine represents a promising perspective on therapeutic angiogenesis in patients with cardiovascular disease, including heart failure.
临床研究部分采用随机对照的方法，治疗心力衰竭患者60例。并分为两组。
Clinical research: we cure 60 patients of heat failure, and divide to two teams with random and compared ways.
适合的患者是很虚弱的，因这种病导致导致呼吸困难、劳累和充血性心力衰竭。
The patients who qualified were debilitated by the disease, which causes shortness of breath, fatigue and congestive heart failure.
目的：评价心率变异性在充血性心力衰竭患者的临床应用价值。
Aim: To evaluate clinical value of the heart rate variability in patients with congestive heart failure.
正五聚蛋白3，一个新的血管炎症因子，预示着心力衰竭患者的不良预后。
Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
在使用匹格列酮的患者中，严重的心力衰竭增加，但是没有引起与之相关的死亡率的增加。
Serious heart failure is increased in patients on pioglitazone, although there is no associated increase in mortality.
目前舒张性心力衰竭(DHF)占所有心衰患者的50%以上。
Diastolic heart failure (DHF) currently accounts for more than 50% of all heart failure patients.
目的：观察米力农对充血性心力衰竭患者的临床疗效。
Objective To observe the effect of milrinone for patients with congestive heart failure.
对于抗栓治疗在慢性心力衰竭患者中的地位一直存在争议。
The role of antithrombotic therapy in patients with chronic heart failure has long been debated.
我们通过三明治酶联免疫吸附试验测量了196名心力衰竭患者和60名非心力衰竭对照者的血清ptx3水平。
We measured the plasma PTX3 levels in 196 patients with heart failure and 60 control subjects without heart failure by sandwich enzyme-linked immunosorbent assay.
目的观察卡维地洛治疗慢性心力衰竭患者的临床疗效。
Objective To investigate the effect of Carvedilol in the treatment of chronic heart failure.
慢性肾脏疾病患者的心力衰竭和控制慢性肾脏疾病在预防心衰中的作用的关系需要进一步研究。
The relationship of chronic kidney disease to HF and control of chronic kidney disease in prevention of HF need further investigation.
这项研究的目的是探讨血清ptx3水平在心力衰竭患者患者中的临床意义。
The purpose of the present study was to examine the clinical significance of plasma PTX3 levels in patients with heart failure.
目的：研究慢性心力衰竭(CHF)患者血清胆红素水平变化与临床的关系。
Objective: To observe the Clinical changes of level of serum bilirubin in patients with chronic congestive heart failure (CHF).
目的探讨有氧运动训练对慢性心力衰竭患者骨骼肌功能的影响。
Objective To investigate the effects of aerobic exercise on skeletal muscle function in patients with chronic heart failure.
结论序贯透析对慢性肾功能衰竭并发心力衰竭患者的应用，具有临床治疗价值，值得推广。
Cooclusions SD is an attractive method that can be used in the treatment of the CRF patients with heart failure.
目的：探讨心力衰竭患者进行运动康复治疗的有效性和安全性。
Objective To test the efficacy and safety of exercise training among patients with heart failure.
结果：心力衰竭患者的血浆BNP与中医证型显著相关。
Results: There is a significant correlation between plasma BNP and TCM syndrome in patients with heart failure.
目的：观察中性内肽酶(NEP)在心力衰竭(心衰)患者淋巴细胞中的表达。
Objective: To detect neutral endopeptidase (NEP) expression in lymphocytes of patients with congestive heart failure.
目前心力衰竭患者的数量正在逐年增加，心脏再同步化治疗越来越受到人们的重视。
At present the number of patients with heart failure is annually increasing, cardiac resynchronization therapy is attracting more and more attention.
目前心力衰竭患者的数量正在逐年增加，心脏再同步化治疗越来越受到人们的重视。
At present the number of patients with heart failure is annually increasing, cardiac resynchronization therapy is attracting more and more attention.
应用推荐